Back to Search
Start Over
AcelRx Pharmaceuticals Announces Divestment of DSUVIA to Alora Pharmaceuticals
- Source :
- PR Newswire. March 14, 2023
- Publication Year :
- 2023
-
Abstract
- Agreement with Alora Pharmaceuticals provides AcelRx with 15% royalties on commercial sales, 75% royalties on Department of Defense (DoD) sales, up to $116.5 million in potential sales-based milestone payments, and [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PR Newswire
- Publication Type :
- News
- Accession number :
- edsgcl.741152076